Citation Impact
Citing Papers
Functionally specialized junctions between endothelial cells of lymphatic vessels
2007 Standout
Conjunctival Goblet Cell Secretion Stimulated by Leukotrienes Is Reduced by Resolvins D1 and E1 To Promote Resolution of Inflammation
2011
Ginger—An Herbal Medicinal Product with Broad Anti-Inflammatory Actions
2005 Standout
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
2001 Standout
The Leukotriene C4 Transporter MRP1 Regulates CCL19 (MIP-3β, ELC)–Dependent Mobilization of Dendritic Cells to Lymph Nodes
2000
Clonidine Prevents Methylxanthine Stimulation of Norepinephrine Metabolism in Rat Brain
1983
Selectivity of Recombinant Human Leukotriene D4, Leukotriene B4, and Lipoxin A4 Receptors with Aspirin-Triggered 15-epi-LXA4 and Regulation of Vascular and Inflammatory Responses
2001
Δ12-Prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes
2005
Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation
2005 Standout
LEUKOTRIENES, LEUKOTRIENE RECEPTOR ANTAGONISTS AND LEUKOTRIENE SYNTHESIS INHIBITORS IN ASTHMA: AN UPDATE. PART I: SYNTHESIS, RECEPTORS AND ROLE OF LEUKOTRIENES IN ASTHMA
1999
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
2006 Standout
International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors
2003
Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators
2001
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
Calcium handling and purinoceptor subtypes involved in ATP‐induced contraction in rat small mesenteric arteries.
1996
The use of dendritic cells in cancer immunotherapy
2003 StandoutNobel
Antispasmodic effects of eugenol on rat airway smooth muscle
2010
Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells
2003 Standout
The effect of leukotriene synthesis inhibitors in models of acute and chronic inflammation
1996
A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene–receptor antagonist
1998
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Some interfaces of dendritic cell biology
2003 StandoutNobel
TRPM8 Is Required for Cold Sensation in Mice
2007 StandoutNobel
Transient receptor potential (TRP) channels as potential drug targets in respiratory disease
2003
Substance P induces biphasic endothelium-dependent relaxations in pig and rabbit carotid arteries
1994 StandoutNobel
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Polyketide biosynthesis: a millennium review
2001 Standout
TFOS DEWS II Management and Therapy Report
2017 Standout
Identification, Molecular Cloning, Expression, and Characterization of a Cysteinyl Leukotriene Receptor
1999
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders
2004 Standout
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
2003 Standout
A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
1995 Standout
Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera Dunal. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum
2001
The expanding superfamily of phospholipase A2 enzymes: classification and characterization
2000 Standout
Points of control in inflammation
2002 StandoutNature
Asthma Therapy with Agents Preventing Leukotriene Synthesis or Action
1999
8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro.
1996
The Glut athione S-Transferase Supergene Family: Regulation of GST and the Contribution of the lsoenzymes to Cancer Chemoprotection and Drug Resistance Part I
1995 Standout
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Theophylline inhibits tolerance and sensitization induced by morphine: a conditioned place preference paradigm study in female mice
2006
FR 113680: a novel tripeptide substance P antagonist with NK1 receptor selectivity
1992
Alcoholic extract of ‘Bacopa monniera’ reduces the in vitro effects of morphine withdrawal in guinea-pig ileum
2002
Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects
1992 Standout
Mast cells in the development of adaptive immune responses
2005 Standout
Alternative activation of macrophages
2003 Standout
A Molecular and Cellular Theory of Depression
1997 Standout
Asthma
2000 Standout
Pharmacological Characterization of Leukotriene Receptors
2000
Effects of LTD 4 on Human Airway Smooth Muscle Cell Proliferation, Matrix Expression, and Contraction In Vitro : Differential Sensitivity to Cysteinyl Leukotriene Receptor Antagonists
1998
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory
1998 StandoutNobel
Eugenol—From the Remote Maluku Islands to the International Market Place: A Review of a Remarkable and Versatile Molecule
2012 Standout
Cellular site of opiate dependence
1980 Nature
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
2012 Standout
Prostanoid Receptors: Structures, Properties, and Functions
1999 Standout
Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene.
1994
Receptors for Purines and Pyrimidines
1998 Standout
The Physiological Role of Adenosine In The Central Nervous System
1985
Cyclooxygenases: Structural, Cellular, and Molecular Biology
2000 Standout
Update on the status of DP2 receptor antagonists; from proof of concept through clinical failures to promising new drugs
2013
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
2000 StandoutNatureNobel
Inflammation and Cellular Immune Responses in Abdominal Aortic Aneurysms
2006 Standout
Mu and kappa opioid receptor agonists antagonize icilin-induced wet-dog shaking in rats
2006
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
1995 Standout
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use
1999 Standout
Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3?,5?-monophosphate phosphodiesterase inhibitors
1982
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
2013
Cellular and Molecular Mechanisms of Drug Dependence
1988 StandoutScience
Withanolide Derivatives from the Roots of Withania somnifera and Their Neurite Outgrowth Activities.
2002 Standout
Microsomal glutathione S-transferase is the predominant leukotriene C4 binding site in cellular membranes.
1994
Methylxanthines: possible mechanisms of action in brain
1980
Basic and clinical aspects of adenosinergic neuromodulation
1985
Receptors for Purines and Pyrimidines
2012 Standout
Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors
1983
Microglial M1/M2 polarization and metabolic states
2015 Standout
Prostaglandins and Inflammation
2011 Standout
Synthesis and Structure−Activity Relationships of Carboxylated Chalcones: A Novel Series of CysLT1 (LTD4) Receptor Antagonists
1997
Cysteinyl Leukotrienes and Their Receptors: Cellular Distribution and Function in Immune and Inflammatory Responses
2004
Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors
1986
Prostaglandin D2Inhibits Inducible Nitric Oxide Synthase Expression in Rat Vascular Smooth Muscle Cells
1998
Works of Nigel J. Cuthbert being referenced
Characterisation of the peptido-leukotriene receptor PL2 on the ferret spleen strip
1993
BAY u9773, a novel antagonist of cysteinyl-leukotrienes with activity against two receptor subtypes
1994
Inhibition of antigen-induced contraction of guinea-pig airways by a leukotriene synthesis inhibitor, BAY x1005
1994
BAY u3405, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro
1991
The binding of [3H]leukotriene C4 to guinea-pig lung membranes. The lack of correlation of LTC4 functional activity with binding affinity
1987
Evidence for two leukotriene receptor types in the guinea-pig isolated ileum
1990
Characterisation of the Leukotriene Receptor(s) on Human Isolated Lung Strips
1988
The inhibition of [3H]leukotriene D4 binding to guinea-pig lung membranes. The correlation of binding affinity with activity on the guinea-pig ileum
1990
MODEL OF OPIATE DEPENDENCE IN THE GUINEA‐PIG ISOLATED ILEUM
1981
Roles of Ca2+ influx and intracellular Ca2+ release in agonist-induced contractions in guinea pig trachea
1994
A second cysteinyl leukotriene receptor in human lung.
1992
CLONIDINE DEPENDENCE IN THE GUINEA‐PIG ISOLATED ILEUM
1981
A new structural analogue antagonist of peptido-leukotrienes. The discovery of bay x7195
1993
Characterisation of leukotriene receptors on rat lung strip
1994
Mechanism of quasi-morphine withdrawal behaviour induced by methylxanthines
1979